Artificial cell membrane camouflaged immunomagnetic nanoparticles for enhanced circulating tumor cell isolation

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Diagnostics

Background:

• Circulating tumor cell (CTC) isolation is crucial for cancer diagnostics but is hindered by interfering blood cells and proteins.
• Existing cell membrane-derived platforms face challenges like complex composition, batch variability, and difficult cell expansion, limiting commercialization.

Purpose of the Study:

• To develop an artificial cell membrane camouflage strategy for immunomagnetic nanoparticles (AIMNPs) to enhance CTC isolation.
• To overcome the limitations of current CTC isolation techniques by creating a more robust and commercially viable platform.

Main Methods:

• Fabrication of AIMNPs using commercialized lipids (biotinylated phospholipid) and proteins (human serum albumin, HSA) on graphene nanosheets (GNs).
• Antibody modification on biotinylated phospholipids for specific targeting.
• Integration of biomimetic cell membrane onto magnetic nanoparticles via lipid and protein adsorption.

Main Results:

• AIMNPs demonstrated high specificity with an average capture efficiency of 87.0% for CTCs.
• Achieved good sensitivity, detecting as few as 7 model CTCs per 0.5 mL.
• Exhibited enhanced anti-nonspecific absorption, capturing only 15-105 white blood cells per 1.5 mL in mimic and clinical blood samples.

Conclusions:

• Artificial cell membrane camouflage provides a viable strategy to overcome limitations in CTC isolation platforms.
• AIMNPs offer a promising tool for precise and specific CTC isolation with potential for clinical applications and commercialization.